← Back to headlines
Stifel Cuts Medtronic (MDT) Target to $95 Citing MiniMed IPO Effects
Stifel has lowered its price target for Medtronic (MDT) to $95, attributing the adjustment to the anticipated effects of the MiniMed IPO.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
